EthOss TCP - Dental bone matrix implant, synthetic
Country: Awstralja
Lingwa: Ingliż
Sors: Department of Health (Therapeutic Goods Administration)
Rapport ta 'Valutazzjoni Pubblika
(PAR)
28-05-2019
Xi dokumenti għal dan il-prodott mhumiex disponibbli bħalissa, tista 'tibgħat talba lis-servizz tal-konsumatur tagħna u aħna ninnotifikawkom malli nkunu nistgħu niksbuhom.
Ibgħat talba.
Ibgħat talba.
Disponibbli minn:
W9 Pty Ltd
Klassi:
Class III
Manifatturat minn:
Medbone-Medical Devices Lda Centro Empresarial Lusoworld II R Pe de Mouro 26 , Sintra, 2710-335 Portugal
Żona terapewtika:
47971 - Dental bone matrix implant, synthetic
Indikazzjonijiet terapewtiċi:
EthOss TCP is a synthetic, resorbable, osteoconductive bone graft material composed of 65% beta tricalcium phosphate (?-TCP) and 35% medical grade calcium sulfate (CaSO4). It is provided as a dry powder packaged within a syringe to be mixed with sterile saline to form a paste and applied through the syringe. EthOss TCP is intended to fill, augment, or reconstruct periodontal or bony defects of the oral and maxillofacial region.
L-istatus ta 'awtorizzazzjoni:
A
Data ta 'l-awtorizzazzjoni:
2018-02-22
